178 related articles for article (PubMed ID: 30033183)
41. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
[TBL] [Abstract][Full Text] [Related]
42. Bilateral autogenous breast reconstruction using perforator free flaps: a single center's experience.
Hamdi M; Blondeel P; Van Landuyt K; Tondu T; Monstrey S
Plast Reconstr Surg; 2004 Jul; 114(1):83-9; discussion 90-2. PubMed ID: 15220573
[TBL] [Abstract][Full Text] [Related]
43. Reoperations after prophylactic mastectomy with or without implant reconstruction.
Zion SM; Slezak JM; Sellers TA; Woods JE; Arnold PG; Petty PM; Donohue JH; Frost MH; Schaid DJ; Hartmann LC
Cancer; 2003 Nov; 98(10):2152-60. PubMed ID: 14601084
[TBL] [Abstract][Full Text] [Related]
44. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
[TBL] [Abstract][Full Text] [Related]
45. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
Tuttle TM; Habermann EB; Grund EH; Morris TJ; Virnig BA
J Clin Oncol; 2007 Nov; 25(33):5203-9. PubMed ID: 17954711
[TBL] [Abstract][Full Text] [Related]
46. Breast Cancer Knowledge and Decisions Made for Contralateral Prophylactic Mastectomy: A Survey of Surgeons and Women in the General Population.
Hooper RC; Hsu J; Duncan A; Bensenhaver JM; Newman LA; Kidwell KM; Chung KC; Momoh AO
Plast Reconstr Surg; 2019 May; 143(5):936e-945e. PubMed ID: 31033815
[TBL] [Abstract][Full Text] [Related]
47. National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer.
Panchal H; Pilewskie ML; Sheckter CC; Albornoz CR; Razdan SN; Disa JJ; Cordeiro PG; Mehrara BJ; Matros E
J Surg Oncol; 2019 Jan; 119(1):79-87. PubMed ID: 30480805
[TBL] [Abstract][Full Text] [Related]
48. Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database.
Osman F; Saleh F; Jackson TD; Corrigan MA; Cil T
Ann Surg Oncol; 2013 Oct; 20(10):3212-7. PubMed ID: 23846780
[TBL] [Abstract][Full Text] [Related]
49. Trends in unilateral breast reconstruction and management of the contralateral breast: the Emory experience.
Losken A; Carlson GW; Bostwick J; Jones GE; Culbertson JH; Schoemann M
Plast Reconstr Surg; 2002 Jul; 110(1):89-97. PubMed ID: 12087236
[TBL] [Abstract][Full Text] [Related]
50. Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral Versus Bilateral Reconstructions.
Wade RG; Razzano S; Sassoon EM; Haywood RM; Ali RS; Figus A
Ann Surg Oncol; 2017 Jun; 24(6):1465-1474. PubMed ID: 28229288
[TBL] [Abstract][Full Text] [Related]
51. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
52. Predictors for contralateral prophylactic mastectomy in breast cancer patients.
Fu Y; Zhuang Z; Dewing M; Apple S; Chang H
Int J Clin Exp Pathol; 2015; 8(4):3748-64. PubMed ID: 26097557
[TBL] [Abstract][Full Text] [Related]
53. Prophylactic mastectomy for the prevention of breast cancer.
Lostumbo L; Carbine N; Wallace J; Ezzo J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
[TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness Analysis of Contralateral Prophylactic Mastectomy Compared to Unilateral Mastectomy with Routine Surveillance for Unilateral, Sporadic Breast Cancer.
Keskey RC; LaJoie AS; Sutton BS; Kim IK; Cheadle WG; McMasters KM; Ajkay N
Ann Surg Oncol; 2017 Dec; 24(13):3903-3910. PubMed ID: 29039025
[TBL] [Abstract][Full Text] [Related]
55. Short-Term Complications Associated With Acellular Dermal Matrix-Assisted Direct-to-Implant Breast Reconstruction.
Hunsicker LM; Ashikari AY; Berry C; Koch RM; Salzberg CA
Ann Plast Surg; 2017 Jan; 78(1):35-40. PubMed ID: 26849284
[TBL] [Abstract][Full Text] [Related]
56. Indications for Contralateral Prophylactic Mastectomy: A Consensus Statement Using Modified Delphi Methodology.
Wright FC; Look Hong NJ; Quan ML; Beyfuss K; Temple S; Covelli A; Baxter N; Gagliardi AR
Ann Surg; 2018 Feb; 267(2):271-279. PubMed ID: 28594745
[TBL] [Abstract][Full Text] [Related]
57. Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction.
Koslow S; Pharmer LA; Scott AM; Stempel M; Morrow M; Pusic AL; King TA
Ann Surg Oncol; 2013 Oct; 20(11):3422-9. PubMed ID: 23720070
[TBL] [Abstract][Full Text] [Related]
58. Bilateral breast reconstruction with the deep inferior epigastric perforator (DIEP) flap: an experience with 280 flaps.
Guerra AB; Metzinger SE; Bidros RS; Rizzuto RP; Gill PS; Nguyen AH; Dupin CL; Allen RJ
Ann Plast Surg; 2004 Mar; 52(3):246-52. PubMed ID: 15156976
[TBL] [Abstract][Full Text] [Related]
59. Management of Mastectomy Skin Necrosis in Implant Based Breast Reconstruction.
Sue GR; Long C; Lee GK
Ann Plast Surg; 2017 May; 78(5 Suppl 4):S208-S211. PubMed ID: 28301366
[TBL] [Abstract][Full Text] [Related]
60. Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer.
S Chapman J; Roddy E; Panighetti A; Hwang S; Crawford B; Powell B; Chen LM
Clin Breast Cancer; 2016 Dec; 16(6):494-499. PubMed ID: 27495996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
